EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Endogenous retroviruses in development, immunity, and disease: From regulatory roles to therapeutic opportunities

Cheng Yan, Wang Li, Linjie Peng, Juan Xu, Chenglin Zhou

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-07 · 1881 (3) · 189574

DOI: 10.1016/j.bbcan.2026.189574 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-07. Verfasst von Cheng Yan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory Center, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China. Hauptthemen laut MEDLINE: Endogenous Retroviruses, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 159 Literaturangaben. Gefördert von: Nanjing Medical University, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endogenous retroviruses (ERVs), representing nearly 8% of the human genome, have transitioned from ancient viral remnants to pivotal regulators of host biology. Once integrated into germline DNA, ERVs accumulated sequence divergence and epigenetic silencing, yet many retained functional long terminal repeats (LTRs) and protein-coding genes that were repurposed for host development, immunity, and genome regulation. Recent studies reveal that ERVs act as lineage-specific enhancers, promoters, and RNA regulators, orchestrating processes ranging from embryonic cell fate decisions to antiviral defense. Dysregulation of ERVs, however, drives diverse pathologies, including oncogenesis, autoimmunity, neurodegeneration, and microbiota-immune imbalance. Mechanistically, ERVs reactivation shapes tumor microenvironments, induces chronic inflammation, and contributes to epigenetic instability during aging. These insights have sparked growing interest in ERVs as diagnostic biomarkers and therapeutic targets. Epigenetic drugs exploiting ERVs reactivation for "viral mimicry" immunotherapy, CRISPR-based strategies for targeted ERV silencing, and ERV-derived neoantigens for precision oncology exemplify emerging translational avenues. Future integration of single-cell omics, genome editing, and immunogenomics promises to elucidate ERVs regulatory networks and accelerate the development of ERV-centered diagnostics and therapeutics. Collectively, ERVs embody a molecular nexus linking evolution, development, immunity, and disease, offering transformative potential for precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endogenous RetrovirusesNeoplasmsHumansAnimalsEpigenesis, GeneticTumor Microenvironment

Stichwörter der Autor:innen

Endogenous retrovirusesEpigenetic regulationImmunity and diseaseTherapeutic opportunities

Autor:innen und Institutionen

  • Clinical Laboratory Center, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China.
  • Clinical Laboratory Center, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China. Electronic address: xujuan20230419@njmu.edu.cn.
  • Clinical Laboratory Center, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China. Electronic address: zhouchenglin@njmu.edu.cn.

Förderung

  • Nanjing Medical University
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • National Key Clinical Specialty Discipline Construction Program of China

Zitieren

APA

Yan, C., Li, W., Peng, L., Xu, J., & Zhou, C. (2026). Endogenous retroviruses in development, immunity, and disease: From regulatory roles to therapeutic opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(3), 189574. https://doi.org/10.1016/j.bbcan.2026.189574

Vancouver

Yan C, Li W, Peng L, Xu J, Zhou C. Endogenous retroviruses in development, immunity, and disease: From regulatory roles to therapeutic opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(3):189574. doi:10.1016/j.bbcan.2026.189574

BibTeX
@article{Yan2026,
  author = {Yan, Cheng and Li, Wang and Peng, Linjie and Xu, Juan and Zhou, Chenglin},
  title = {Endogenous retroviruses in development, immunity, and disease: From regulatory roles to therapeutic opportunities},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  volume = {1881},
  number = {3},
  pages = {189574},
  doi = {10.1016/j.bbcan.2026.189574}
}
Kostenlos starten →